Asthma Trial, Recruiting NCT07110116 Sponsor: Riphah International University Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT07110116
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a man or woman between 18 and 60 years old who has been diagnosed with asthma
  • Your asthma is considered mild to moderate, based on a breathing test result showing your lungs are working at 60–80% of the expected level for someone your age and size
  • Your asthma has been stable recently, meaning you have not had a sudden worsening of symptoms
  • You are able to follow instructions and perform a standard breathing test called spirometry
  • You have not had a respiratory infection (such as a chest infection or cold affecting your breathing) recently

Who may not be able to join:

  • Your asthma is classified as severe, meaning your breathing test shows your lungs are working at less than 60% of the expected level
  • You currently have a respiratory infection, have recently had a sudden worsening of your asthma, or have other significant health conditions alongside your asthma
  • You are unable to do breathing exercises or complete the breathing test required by the trial
  • You are currently taking certain medications, including steroid tablets taken by mouth or beta-blocker medicines
  • You are pregnant, due to possible risks associated with the breathing exercises used in this trial

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Muhammad Iqbal Tariq, PhD*, Riphah International University

Phone: 03338236752

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 August 2025
Est. completion
1 November 2025

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Forced expiratory volume in 1 second; Forced Vital Capicity; Peak Expiratory Flow Rate; Asthama Control Test; Asthama Quality of Life Questionaire with standardized Activities

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov